Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System Lymphoma (PCNSL)[E1F05]

Lode J. Swinnen, MBChB, Anne O'Neill, Philip H Imus, MD, Sachin Gujar, MBBS, MD, David Schiff, MD, Lawrence Kleinberg, Ranjana Advani, Erin Dunbar, MD, Dennis F. Moore, Jr., MD, Stuart Grossman, MD

Blood (2015) 126 (23): 1530.

https://doi.org/10.1182/blood.V126.23.1530.1530

Published: 2015

Journal Articles

Lymphoproliferative Disease Risk in Patients with Autoimmune Disease: Clustering of Primary CNS Lymphoma with Drug Regimen and Disease Process

Genevieve Marie Crane, MD PhD, Helen Powell, PhD, Rumen Kostadinov, PhD, Peter C. Burger, MD, Richard F. Ambinder, MD PhD, Lode J. Swinnen, MBChB, Michael J. Borowitz, MD PhD, Amy S. Duffield, MD PhD

Blood (2015) 126 (23): 1490.

https://doi.org/10.1182/blood.V126.23.1490.1490

Published: 2015

Journal Articles

Feasibility of Interim PET-Adapted Therapy in HIV-Positive Patients with Advanced Hodgkin Lymphoma (HL): Sub-Analysis of SWOG S0816 Phase 2 Trial

Alexey V Danilov, MD PhD, Hongli Li, PhD, Oliver W. Press, Ilan Shapira, MD, Lode J. Swinnen, MBChB, Ariela Noy, MD, Erin Reid, MD, Sonali M. Smith, MD, Jonathan W. Friedberg, MD MMSc

Blood (2015) 126 (23): 1498.

https://doi.org/10.1182/blood.V126.23.1498.1498

Published: 2015

Journal Articles

Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CHOP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.

Ranjana H Advani, MD, Fangxin Hong, Ph.D., Kristen N. Ganjoo, MD, Judith B. Manola, MS, Lode J. Swinnen, MBChB, Thomas M Habermann, MD, Sandra J Horning, MD

Blood (2009) 114 (22): 1671.

https://doi.org/10.1182/blood.V114.22.1671.1671

Published: 2009

Journal Articles

Interim Positron Emission Tomography (PET) in Diffuse Large B-Cell Lymphoma: Independent Expert Nuclear Medicine Evaluation of ECOG 3404

Sandra J. Horning, MD, Malik E. Juweid, MD, Heiko Schoder, Gregory Wiseman, MD, Alex McMillan, Ph.D., Lode J. Swinnen, MBChB, Ranjana Advani, MD, Randy D. Gascoyne, MD, Andrew Quon

Blood (2008) 112 (11): 372.

https://doi.org/10.1182/blood.V112.11.372.372

Published: 2008

NARROW

Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System Lymphoma (PCNSL)[E1F05]

Lymphoproliferative Disease Risk in Patients with Autoimmune Disease: Clustering of Primary CNS Lymphoma with Drug Regimen and Disease Process

Feasibility of Interim PET-Adapted Therapy in HIV-Positive Patients with Advanced Hodgkin Lymphoma (HL): Sub-Analysis of SWOG S0816 Phase 2 Trial

Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CHOP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.

Interim Positron Emission Tomography (PET) in Diffuse Large B-Cell Lymphoma: Independent Expert Nuclear Medicine Evaluation of ECOG 3404

Email alerts

ASH Publications

American Society of Hematology

Phase II Study of Rituximab Given in Conjunction with Standard Chemotherapy in Primary Central Nervous System Lymphoma (PCNSL)[E1F05]

Lymphoproliferative Disease Risk in Patients with Autoimmune Disease: Clustering of Primary CNS Lymphoma with Drug Regimen and Disease Process

Feasibility of Interim PET-Adapted Therapy in HIV-Positive Patients with Advanced Hodgkin Lymphoma (HL): Sub-Analysis of SWOG S0816 Phase 2 Trial

Cardiac Toxicity Associated with the Anti-VEGF Monoclonal Antibody Bevacizumab (Avastin) in Combination with CHOP (A-CHOP) Chemotherapy for Peripheral T Cell Lymphoma (PTCL): The ECOG 2404 Trial.

Interim Positron Emission Tomography (PET) in Diffuse Large B-Cell Lymphoma: Independent Expert Nuclear Medicine Evaluation of ECOG 3404

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only